World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2540)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

253

HTML

1992

Figures (1-1)

180

Tables (1-2)

115

Sum=2540

May 28, 2008 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Weber A, Huber W, Kamereck K, Winkle P, Voland P, Weidenbach H, Schmid RM, Prinz C. In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis. World J Gastroenterol 2008; 14(20): 3174-3178 [PMID: 18506921 DOI: 10.3748/wjg.14.3174]
URL:	https://www.wjgnet.com/1007-9327/full/v14/i20/3174.htm

Number	Citing Articles
1	J. Schneider, W. Weidner, A. Hapfelmeier, N. Wantia, S. Feihl, R. M. Schmid, B. Neu, S. von Delius, H. Algül, W. Huber, A. Weber. The use of proton pump inhibitors and the spectrum and number of biliary pathogens in patients with acute cholangitis. Alimentary Pharmacology & Therapeutics 2014; 39(10): 1194 doi: 10.1111/apt.12694
2	Erik Rosa-Rizzotto, Diego Caroli, Laura Scribano. Diseases of the Liver and Biliary Tree. 2021; : 195 doi: 10.1007/978-3-030-65908-0_12
3	M. C. Ober, T. Hoppe-Tichy, J. Koninger, O. Schunter, H.-G. Sonntag, M. A. Weigand, J. Encke, C. Gutt, S. Swoboda. Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections. Journal of Antimicrobial Chemotherapy 2009; 64(5): 1091 doi: 10.1093/jac/dkp318
4	Fu-Yu Li, Nan-Sheng Cheng, Jing-Qiu Cheng, Hui Mao, Li-Sheng Jiang, Ning Li, Sheng He. Treatment of chronic proliferative cholangitis with c-myc shRNA . World Journal of Gastroenterology 2009; 15(1): 95-101 doi: 10.3748/wjg.15.95 Abstract(1189) \| Core Tip(633) \| Full Article(HTML)(2356) \| Full Article (PDF)-909K(290) \| Times Cited (9) \| Total Visits (4931) \| Open
5	Amir Houshang Mohammad Alizadeh. Cholangitis: Diagnosis, Treatment and Prognosis. Journal of Clinical and Translational Hepatology 2017; 5(4): 1 doi: 10.14218/JCTH.2017.00028
6	Nam Hee Kim, Hong Joo Kim, Ki Bae Bang. Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis. Hepatobiliary & Pancreatic Diseases International 2017; 16(5): 512 doi: 10.1016/S1499-3872(17)60056-0
7	Xue-Xiang Gu, Meng-Pei Zhang, Yan-Feng Zhao, Guang-Ming Huang. Clinical and microbiological characteristics of patients with biliary disease. World Journal of Gastroenterology 2020; 26(14): 1638-1646 doi: 10.3748/wjg.v26.i14.1638 Abstract(478) \| Core Tip(497) \| Full Article(HTML)(3157) \| Full Article (PDF)-1158K(422) \| Full Article (Word)-243K(145) \| Audio-930K(11) \| Peer-Review Report-364K(147) \| Answering Reviewers-119K(104) \| Supplementary Material-62K(87) \| Times Cited (12) \| Total Visits (9660) \| Open
8	Christoph Justinger, Martin K. Schilling, Martin G. Kees, Anne Kauffels, Katrin Hirschmann, Berit Kopp, Frieder Kees, Otto Kollmar. Penetration of moxifloxacin into liver tissue. International Journal of Antimicrobial Agents 2012; 39(6): 505 doi: 10.1016/j.ijantimicag.2012.01.022
9	Markus Rentsch, Martin Angele, Markus Guba. Komplikationsmanagement in der Chirurgie. 2015; : 221 doi: 10.1007/978-3-662-43475-8_21